1.Expression of reconstructed BCR-ABL-pIRES-SEA plasmids in the skeletal muscles of BALB/c mice.
Yongpeng GAO ; Yanan QIN ; Chen LIN ; Hongxia TIAN ; Chen CHEN ; Yubing ZHOU ; Yangqiu LI
Journal of Biomedical Engineering 2012;29(3):519-523
This paper is aimed to investigate the transcription and expression of BCR-ABL-pIRES-SEA fusion gene vaccines in vivo in mice. The reconstructed plasmids (BCR-ABL-pIRES-SEA) which were developed previously in our laboratory were injected into the skeletal muscles of BALB/c mice at 14d intervals for three cycles. The transcription and expression of BCR-ABL and staphylococcal enterotoxin A (SEA) in injection site were detected using RT-PCR and immunohistological methods. The BCR-ABL/SEA mRNA and protein could be identified in the injection site of BCR-ABL-pIRES-SEA vaccinated mice. The reconstructed BCR-ABL-pIRES-SEA plasmids can effectively express gene production in the skeletal muscles of mice and have the common features of DNA vaccine.
Animals
;
Enterotoxins
;
genetics
;
immunology
;
metabolism
;
Fusion Proteins, bcr-abl
;
genetics
;
immunology
;
metabolism
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Muscle, Skeletal
;
metabolism
;
Plasmids
;
immunology
;
RNA, Messenger
;
genetics
;
metabolism
;
Recombinant Fusion Proteins
;
genetics
;
immunology
;
metabolism
;
Vaccines, DNA
;
administration & dosage
;
immunology
2.Filtrating smooth muscle progenitor cells from mouse bone marrow mesenchymal stem cells by recombinant Psm22alpha-EGFP-1.
Chinese Journal of Pathology 2007;36(12):825-831
OBJECTIVETo identify and select smooth muscle progenitor cells from mouse bone marrow mesenchyme stem cell population and to characterize smooth muscle progenitor cells in peripheral blood.
METHODSRecombinant expression vector with the promoter of sm22alpha was constructed to have an enhancement type green fluorescent protein expression plasmid (EGFP-1). The construct was transfected into mouse bone marrow mesenchyme stem cells using Lipofectamine 2000. Morphological assessment was performed and the expressions of myocardin at protein and mRNA levels by fluorescence microscope and RT-PCR were evaluated at 3, 5, 7, and 10 d targeting CD34 positive bone mesenchyme stem cells.
RESULTSThe transfection efficiency of the positive control group was 70% +/- 1.5% (P > 0.05). Expected green fluorescent proteins expressed at 3rd day. The numbers of green fluorescent cells in experimental groups increased with the time and reached the peak at the 7th day, and declined thereafter. The shapes of the green fluorescent cells were also different from each others. The positive ratios of green fluorescent cells at different time points: 3 d: 7% +/- 0.13%, 5 d: 10% +/- 0.32%, 7 d: 20% +/- 0.26%, 10 d: 12% +/- 0.18%, P < 0.05. Myocardin mRNA expression roughly correlated with green fluorescent expressions. CD34 was expressed on the 5th day in transfected bone mesenchyme stem cells. The CD34 positive ratio was 5.2% +/- 0.21% (P > 0.05).
CONCLUSIONSThere are smooth muscle progenitor cells among mouse bone marrow mesenchyme stem cell population. Smooth muscle progenitor cells can be selected using a Psm22alpha-EGFP-1 recombinant expression approach.
Animals ; Antigens, CD34 ; immunology ; Bone Marrow Cells ; cytology ; immunology ; Cell Separation ; methods ; Cell Shape ; Green Fluorescent Proteins ; Mesenchymal Stromal Cells ; cytology ; immunology ; Mice ; Microfilament Proteins ; genetics ; Microscopy, Fluorescence ; Muscle Proteins ; genetics ; Myocytes, Smooth Muscle ; cytology ; Nuclear Proteins ; genetics ; metabolism ; Promoter Regions, Genetic ; RNA, Messenger ; genetics ; Recombinant Proteins ; genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Trans-Activators ; genetics ; metabolism ; Transfection
3.Differential Immunohistological Features of Inflammatory Myopathies and Dysferlinopathy.
Jae Hwan CHOI ; Yeong Eun PARK ; Sung Il KIM ; Jeong Il KIM ; Chang Hoon LEE ; Kyu Hyun PARK ; Dae Seong KIM
Journal of Korean Medical Science 2009;24(6):1015-1023
This study was performed in order to characterize the types of the infiltrating cells, and the expression profiles of major histocompatibility complex (MHC) class I and membrane attack complex (MAC) in patients with inflammatory myopathies and dysferlinopathy. Immunohistochemical stains were performed using monoclonal antibodies against several inflammatory cell types, MHC class I, and MAC in muscles from inflammatory myopathies and dysferlinopathy. There was significant difference in the types of infiltrating cells between polymyositis (PM), dermatomyositis (DM), and dysferlinopathy, including significantly high CD4+/CD8+ T cell ratio and B/T cell ratio in DM. In dysferlinopathy, CD4+ T cells were the most abundant and the proportions of infiltrating cell types were similar to those of DM. MHC class I was expressed in muscle fibers of PM and DM regardless of the presence of inflammatory infiltrates. MAC was expressed in necrotic fibers and vessels of PM and DM. One patient with early stage DM had a MAC deposits on endomysial capillaries. In dysferlinopathy, MAC deposit was also observed on the sarcolemma of nonnecrotic fibers. The analysis of inflammatory cells, MHC class I expressions and MAC deposits may help to differentiate dysferlinopathy from idiopathic inflammatory myopathy.
Adult
;
Aged
;
*Dermatomyositis/immunology/pathology
;
Female
;
Genes, MHC Class I
;
Humans
;
Male
;
*Membrane Proteins/genetics/immunology
;
Middle Aged
;
Muscle Fibers, Skeletal/cytology/immunology/pathology
;
*Muscle Proteins/genetics/immunology
;
*Muscular Dystrophies, Limb-Girdle/immunology/pathology
;
*Myositis/immunology/pathology
;
*Polymyositis/immunology/pathology
;
T-Lymphocytes/cytology/immunology/pathology
;
Young Adult
4.Expression of a human myofibrillogenesis regulator 1 gene in E. coli and its immunogenicity.
Tian-bo LI ; Yang HU ; Shuang FENG ; Zeng-yan ZUO ; Yi-guang WANG
Acta Academiae Medicinae Sinicae 2005;27(1):42-47
OBJECTIVETo study the expression of human myofibrillogenesis regulator 1 (MR-1) gene in E. coli and obtain the MR-1 protein and its antibody for further investigation of its biological function.
METHODSExpression vectors pGEX-5X-1, pET30a (+), and pET24a (+), as well as host strain E. coli BL21 (DE3) and BL21-CodonPlus (DE3) -RIL were used for expression of MR-1. MR-1 N-terminal with GST or T7-tag or C-terminal with His-tag, separately, or N terminal with T7-tag and C terminal with His-tag, simultaneously, were fused in plasmids pGEX-5X-1, pET30a (+) , and pET24a (+). The expressed MR-1-T protein, separated and purified by preparative SDS-PAGE, was applied to immunize the rabbits. The titer of the antibody was assayed by ELISA and its immunogenicity was tested by Western blot with pcDNA3/MR-1 transfected human breast cancer cell MCF7.
RESULTSThe MR-1 protein was successfully expressed as inclusion body by fusing its N-terminal with T7-tag in E. coli BL21-CodonPlus (DE3) -RIL. MR-1 protein was purified by electro-elution from SDS-PAGE gel. Using this purified protein, polyclonal antibody in rabbit against MR-1 was essentially generated. ELISA and Western blot showed the titer of this antibody was about 1:10(5) with high immunogenicity.
CONCLUSIONSThe N-terminal fusion tag is the most important mechanism for MR-1 expression. The polyclonal antibody of the generated MR-1 protein in E. coli may be applied for its further biological function studies.
Animals ; Antibodies ; analysis ; Breast Neoplasms ; metabolism ; pathology ; Cell Line, Tumor ; Escherichia coli ; metabolism ; Female ; Genetic Vectors ; Humans ; Immunization ; Muscle Proteins ; biosynthesis ; genetics ; immunology ; Plasmids ; Rabbits ; Recombinant Fusion Proteins ; biosynthesis ; genetics ; immunology ; Transfection
5.Construction and cellular expression of GTF-PAc fusion anti-caries DNA vaccine.
Rong JIA ; Mingwen FAN ; Zhuan BIAN ; Jihua GUO ; Zhi CHEN ; Minquan DU
Chinese Journal of Stomatology 2002;37(6):456-458
OBJECTIVETo construct a fusion anti-caries DNA vaccine pGLUA-P carrying GLU fragment from gtfB gene of Streptococcus mutans GS-5 and A-P fragment including the A region and P region of PAc protein from a DNA anti-caries vaccine pCIA-P, and to investigate its expression in prokaryotic and eukaryotic cells.
METHODSThe sequence of GLU fragment in pGLU plasmid was testified by DNA sequencing. The fusion anti-caries DNA vaccine was constructed by ligating A-P fragment from pCIA-P to pGLU. The expression of GLUA-P fusion protein in E. coli BL21 (DE3) was induced by IPTG and checked by SDS-PAGE electrophoresis. pGLUA-P was transfected in vitro to cultured rat primary muscle cells by cation liposome Dosper, and immunohistochemical method was used to test the expression of GLUA-P fusion protein in cells.
RESULTSGLU sequence was identical with relative sequence of GTF-I (GS-5 strain) in Gene Bank. Recombinant eukaryotic expression plasmid pGLUA-P was confirmed to have both GLU and A-P fragment. After pGLUA-P was transferred into E. coli (DE3), it could express a new 115 000 protein by the induce of IPTG. Specific brown products could be found in the cytoplasm of cultured rat primary muscle cells transfected by pGLUA-P.
CONCLUSIONSFusion anti-caries DNA vaccine pGLUA-P is successfully constructed and confirmed by sequencing and enzymes digestion. Fusion GLUA-P protein can be correctly expressed in prokaryotic and eukaryotic cells.
Animals ; Animals, Newborn ; Bacterial Proteins ; genetics ; metabolism ; Cells, Cultured ; Cloning, Molecular ; Dental Caries ; prevention & control ; Electrophoresis, Polyacrylamide Gel ; Escherichia coli ; genetics ; Gene Expression ; Glucosyltransferases ; genetics ; metabolism ; Membrane Glycoproteins ; Muscle, Skeletal ; cytology ; metabolism ; Plasmids ; genetics ; Rats ; Rats, Wistar ; Recombinant Fusion Proteins ; genetics ; metabolism ; Streptococcal Vaccines ; genetics ; immunology ; therapeutic use ; Streptococcus mutans ; genetics ; immunology ; Transfection ; Vaccines, DNA ; genetics ; therapeutic use
6.5-azacytidine induces cardiac differentiation of P19 embryonic stem cells.
Seung Cheol CHOI ; Ji hyun YOON ; Wan Joo SHIM ; Young Moo RO ; Do Sun LIM
Experimental & Molecular Medicine 2004;36(6):515-523
The P19 embryonal carcinoma cell line is a useful model cells for studies on cardiac differentiation. However, its low efficacy of differentiation hampers its usefulness. We investigated the effect of 5-azacytidine (5-aza) on P19 cells to differentiate into a high-efficacy cardiomyocytes. Embryoid-body-like structures were formed after 6 days with 1 micrometer of 5-aza in a P19 cell monolayer culture, beating cell clusters first observed on day 12, and, the production of beating cell clusters increased by 80.1% (29 of 36-wells) after 18 days. In comparison, the spontaneous beating cells was 33.3% (12 of 36-wells) for the untreated control cells. In response to 1 micrometer of 5-aza, P19 cells expressed bone morphogenetic protein-2 (BMP-2), BMP-4, Bmpr1a and Smad1 at day 6 or 9, and also cardiac markers such as GATA-4, Nkx2.5, cardiac troponin I, and desmin were up-regulated in a time-dependent manner after induction of BMP signaling molecules. Immunocytochemistry revealed the expression of smooth muscle a-actin, sarcomeric a-actinin, cardiac myosin heavy chain, cardiac troponin T and desmin, respectively. The proportion of sarcomeric a-actinin positive cells accounted for 6.48% on day 15 after 5-aza exposure as measured by flow cytometry. This study has demonstrated that 5-aza induces differentiation of P19 cells into cardiomyocytes in a confluent monolayer culture in the absence of prior embryoid formation and dimethyl sulfoxide exposure, depending in part on alteration of BMP signaling molecules. These results suggest that 5-aza treatment could be used as a new method for cardiac differentiation in P19 cells.
Animals
;
Azacitidine/*pharmacology
;
Bone Morphogenetic Proteins/genetics/metabolism
;
Cell Differentiation/drug effects/genetics
;
Cell Line, Tumor
;
Cell Proliferation/drug effects
;
DNA-Binding Proteins/genetics/metabolism
;
Embryo/cytology
;
Gene Expression
;
Homeodomain Proteins/genetics/metabolism
;
Mice
;
Muscle Proteins/analysis/genetics/metabolism
;
Myocytes, Cardiac/*cytology/immunology/physiology
;
Research Support, Non-U.S. Gov't
;
Stem Cells/*drug effects/metabolism
;
Transcription Factors/genetics/metabolism
7.Persistence of Orientia tsutsugamushi in Humans.
Moon Hyun CHUNG ; Jin Soo LEE ; Ji Hyeon BAEK ; Mijeong KIM ; Jae Seung KANG
Journal of Korean Medical Science 2012;27(3):231-235
We investigated the persistence of viable Orientia tsutsugamushi in patients who had recovered from scrub typhus. Blood specimens were available from six patients with scrub typhus who were at 1 to 18 months after the onset of the illness. The EDTA-treated blood specimens were inoculated into ECV304 cells, and cultures were maintained for 7 months. Sequencing of the 56-kDa type-specific antigen gene of O. tsutsugamushi was performed to ascertain the homology of isolates. O. tsutsugamushi was isolated from all six patients, and nucleotide sequences of isolates serially collected from each patient were identical in all five patients in whom nucleotide sequences were compared. One patient relapsed 2 days after completion of antibiotic therapy; two patients complained of weakness for 1 to 2.5 months after the illness; one patient underwent coronary angioplasty 6 months later; and one patient suffered from a transient ischemic attack 8 months later. This finding suggests that O. tsutsugamushi causes chronic latent infection, which may be associated with certain clinical illnesses, preceded by scrub typhus. Antibiotic therapy abates the symptoms of scrub typhus, but does not eradicate O. tsutsugamushi from the human body.
Adult
;
Aged
;
Aged, 80 and over
;
Antigens, Bacterial/genetics
;
Bacterial Proteins/genetics
;
Base Sequence
;
Case-Control Studies
;
Chronic Disease
;
Coronary Artery Disease/etiology
;
DNA, Bacterial/genetics/isolation & purification
;
Female
;
Genes, Bacterial
;
Humans
;
Ischemic Attack, Transient/etiology
;
Male
;
Membrane Proteins/genetics
;
Middle Aged
;
Muscle Weakness/etiology
;
Orientia tsutsugamushi/genetics/immunology/*isolation & purification
;
Recurrence
;
Scrub Typhus/complications/drug therapy/*microbiology
;
Time Factors
8.Down syndrome critical region 1 enhances the proteolytic cleavage of calcineurin.
Ji Eun LEE ; Hyonchol JANG ; Eun Jung CHO ; Hong Duk YOUN
Experimental & Molecular Medicine 2009;41(7):471-477
Down syndrome critical region 1 (DSCR1), an oxidative stress-response gene, interacts with calcineurin and represses its phosphatase activity. Recently it was shown that hydrogen peroxide inactivates calcineurin by proteolytic cleavage. Based on these facts, we investigated whether oxidative stress affects DSCR1-mediated inactivation of calcineurin. We determined that overexpression of DSCR1 leads to increased proteolytic cleavage of calcineurin. Convertsely, knockdown of DSCR1 abolished calcineurin cleavage upon treatment with hydrogen peroxide. The PXIIXT motif in the COOH-terminus of DSCR1 is responsible for both binding and cleavage of calcineurin. The knockdown of overexpressed DSCR1 in DS fibroblast cells also abrogated calcineurin proteolysis by hydrogen peroxide. These results suggest that DSCR1 has the ability to inactivate calcineurin by inducing proteolytic cleavage of calcineurin upon oxidative stress.
Adenoviridae/genetics
;
Adult
;
Animals
;
Calcineurin/antagonists & inhibitors/*metabolism
;
Cells, Cultured
;
Chromatin Immunoprecipitation
;
Down Syndrome/*metabolism/pathology
;
Fibroblasts/metabolism/pathology
;
Humans
;
Hydrogen Peroxide/pharmacology
;
Immunoglobulin G/immunology
;
Intracellular Signaling Peptides and Proteins/*physiology
;
Male
;
Mice
;
Mice, Inbred ICR
;
Muscle Proteins/*physiology
;
Neuroblastoma/genetics/metabolism/pathology
;
Neurons/cytology/metabolism
;
Oxidants/pharmacology
;
Oxidative Stress
;
Peptide Fragments/immunology
;
RNA, Messenger/genetics/metabolism
;
RNA, Small Interfering/pharmacology
;
Rabbits
;
Reverse Transcriptase Polymerase Chain Reaction
;
Skin/pathology
;
Young Adult
9.Endovascular microcoil applied for gene delivery system.
Lin MEI ; Hong-fan SUN ; Li-na TANG ; Jing YANG ; Jin CHANG ; Cun-xian SONG
Acta Academiae Medicinae Sinicae 2005;27(2):190-193
OBJECTIVETo explore the possibility of using an endovascular microcoil as a gene delivery system.
METHODSAnti-adenoviral monoclonal antibodies were covalently attached to the collagen-coated surface of platinum microcoil. These antibodies were used to tether adenovirus encoding green fluorescent protein (Ad-GFP). Cell culture studies with rat arterial smooth muscle cells (A10) assessed transduction on or near the coil. Platinum coils coated with Ad-GFP were implanted into the ligated common carotid artery (CCA) of adult rats in a model of arterial stasis and pressurization. After 7 days, CCA segments were harvested, and coils were removed for histopathology and GFP expression studies, while organs were evaluated by polymerase chain reaction to assess viral biodistribution.
RESULTSIn cell culture studies, GFP-positive smooth muscle cells were detected only on the platinum coil surface. After 7 days, GFP was detected on the harvested platinum coil and in the organizing thrombus within the CCA according to fluorescence microscopy and immunohistochemistry. Morphometric analyses revealed that (13.3 +/- 2.0)% of cells within the organized thrombus were transduced with Ad-GFP via the gene delivery system. Ad-GFP was not detectable by polymerase chain reaction in lung, liver, or kidney.
CONCLUSIONSGene delivery endovascular microcoils represents an interventional device-based gene therapy system that can serve as a suitable platform for either single or multiple gene therapy vectors.
Adenoviridae ; genetics ; immunology ; Aneurysm ; surgery ; Animals ; Antibodies, Viral ; chemistry ; metabolism ; Biological Availability ; Carotid Artery, Common ; drug effects ; metabolism ; surgery ; Cells, Cultured ; Drug Delivery Systems ; instrumentation ; Embolization, Therapeutic ; methods ; Endothelial Growth Factors ; therapeutic use ; Genetic Therapy ; instrumentation ; methods ; Genetic Vectors ; administration & dosage ; chemistry ; Green Fluorescent Proteins ; analysis ; Muscle, Smooth, Vascular ; cytology ; Platinum ; chemistry ; Rats ; Rats, Sprague-Dawley ; Recombinant Proteins ; therapeutic use ; Transduction, Genetic ; instrumentation ; methods